Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New brain wave test could spot concussions faster

NCT ID NCT03710109

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new, non-invasive EEG device that uses flashing lights to detect concussions. Researchers compared the device's results to standard doctor assessments in 150 people with head injuries and healthy controls. The goal was to see if the device could accurately flag possible concussions and guide people to seek medical help.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EEG-based concussion detection device
What this could lead to
If successful, this device could provide a quick, objective way to help decide if someone needs medical care after a head injury.
What could go wrong
The trial was terminated early, so results are limited. The device is not FDA-approved and is only being tested for accuracy, not as a replacement for a doctor's diagnosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

150 people

The number who actually took part.

Started

Oct 2018

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Individuals seeking medical attention at the Mount Sinai Hospital System after experiencing a head injury

Ages

9 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals seeking medical care Mount Sinai Hospital after sustaining a possible concussion. * Healthy Individuals with no recent history of head trauma Exclusion Criteria: * Known history of epilepsy or any other seizure disorder * Legally blind * Reduced capacity to consent if there is not a Legally Authorized Representative (LAR) present

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Concussion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Brain Concussion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Abilities Research Center

    New York, New York, 10029, United States

  • Mount Sinai Beth Israel Hospital

    New York, New York, 10003, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.